Fat-Stem Laboratories has been selected for prestigious European project in tendon repair

Fat-Stem Laboratories was founded with the goals to develop state-of-the-art stem cell therapies for animals. Fat-Stem mainly focuses on stem cell therapy for orthopedic problems in horses and dogs. Since 2018 they developed new products for wound healing.

Fat-Stem is one of the few pioneer companies that conducts research in the therapeutic use of adipose-derived mesenchymal stem cells (ASC) and was the first biotech company in the European Union to offer commercial ASC based therapy for horses with ligament and tendon injuries, as well as for joint disease in horses. On top of that Fat-Stem developed patented products in the field of regenerative medicine.

This company has no equivalent in the market for the breadth of its product range and must now expand marketing. Financial growth is extremely promising. Its owner is a leading researcher in Europe in the control of stem cells. Some products have unique advantages (unique selling points) both in terms of therapeutic efficacy but can also eliminate major surgery with better efficiency. Some products are therapeutically breakthroughs in creating new brand launches. Fat-Stem is continuously looking for investors.

Dr. Guy Wouters , founder of Fat-Stem Laboratories and CEO: "Fat-Stem was founded with the goals to develop state-of-the-art stem cell therapies for animals. Fat-Stem mainly focuses on stem cell therapy for orthopedic problems in horses and dogs. Fat-Stem is one of the few companies that conducts research in the therapeutic use of adipose-derived mesenchymal stem cells (ASC) and was the first biotech company in the European Union to offer commercial ASC based therapy for horses with ligament and tendon injuries, as well as for joint disease in horses."

Dr. Wouters founded Fat-Stem by using a new technology in his R&D team in close collaboration with acknowledged European universities and clinics.